19/05/2014 AstraZeneca rejects takeover price from Pfizer, close to 70 billion pounds or US$118 billion
AstraZeneca Rejects Pfizer's £69bn Final Offer
AstraZeneca Tumbles on Rejected $116B Pfizer Takeover Bid
Pfizer Drops Pursuit Of AstraZeneca
Pfizer Says It Won't Make Offer For AstraZeneca
Pfizer Walks Away From $118 Billion AstraZeneca Deal
AstraZeneca rejected a "final offer" from Pfizer of £55 per share, which valued the company at £69.4 billion. The companies had been meeting since January 2014. If the takeover had proceeded Pfizer would have become the world's biggest drug maker. The transaction would also have been the biggest foreign takeover of a British company.
Explore contextually related video stories in a new eye-catching way. Try Combster now!